Dr. Nicolette Stogios earned her PhD from the Institute of Medical Science at the University of Toronto (UofT) in 2024 and is currently a postdoctoral fellow at the Centre for Addiction and Mental Health (CAMH) in Toronto, Canada. Her research explores the complex relationship between antipsychotic medications, cardiometabolic risk, and cognitive function in individuals with severe mental illness. Through this work, she aims to develop innovative treatment strategies that address both cognitive and metabolic impairments, with the ultimate goal of improving the quality of life for affected individuals.